Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase 1/2 8Phase 3 7Phase NA 3Phase 2/3 2Phase 1 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 109Paclitaxel 65Cyclophosphamide 65Cisplatin 60Carboplatin 56Gemcitabine 48Radiotherapy 45Nivolumab 43fludarabine 38Docetaxel 38Pemetrexed 33Dexamethasone 32Capecitabine 32Lenalidomide 26fludarabine phosphate 25Rituximab 25Radiation 25Ipilimumab 25Doxorubicin 25Irinotecan 24Bevacizumab 24Azacitidine 24Vorinostat 23Vincristine 22Cytarabine 22Temozolomide 20Etoposide 20Oxaliplatin 19Fluorouracil 19atezolizumab 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Has results × Folfox protocol × Clear all
NCT02069041 2018-11-21

A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer

Eli Lilly and Company

Phase 1 Completed
8 enrolled 16 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT00599924 2015-07-15

Study Of Sunitinib Plus FOLFOX In Patients With Solid Tumors

Pfizer

Phase 1 Completed
53 enrolled 31 charts
Gastrointestinal

Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡